Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

✍ Scribed by Christopher M. O'Connor; Wendy A. Gattis; Barry F. Uretsky; Kirkwood F. Adams Jr; Steven E. McNulty; Steven H. Grossman; William J. McKenna; Faiez Zannad; Karl Swedberg; Mihai Gheorghiade; Robert M. Califf

• Book ID: 117011329
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 177 KB
• Volume: 138
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/s0002-8703(99)70250-4